KREBS BIOCHEMICALS & INDUSTRIES
|
KREBS BIOCHEMICALS & INDUSTRIES Last 5 Year Financial Ratios History
[Standalone]
| Mar2023 | Mar2022 | Mar2021 | Mar2020 | Mar2019 | |
|---|---|---|---|---|---|
| Operational & Financial Ratios | |||||
| Earnings Per Share (Rs) | -11.45 | -20.65 | -14.45 | -16.04 | -12.03 |
| CEPS(Rs) | -8.41 | -17.73 | -11.84 | -13.44 | -9.39 |
| DPS(Rs) | - | - | - | - | - |
| Book NAV/Share(Rs) | -46.13 | -34.83 | -23.91 | -18.14 | -8.59 |
| Tax Rate(%) | - | - | - | - | - |
| Margin Ratios | |||||
| Core EBITDA Margin(%) | -30.27 | -56.94 | -32.73 | -55.53 | -20.44 |
| EBIT Margin(%) | -41.66 | -65.55 | -41.12 | -68.45 | -28.74 |
| Pre Tax Margin(%) | -47.36 | -74.58 | -52.81 | -86.41 | -41.90 |
| PAT Margin (%) | -47.36 | -74.58 | -52.81 | -86.41 | -41.90 |
| Cash Profit Margin (%) | -34.78 | -64.03 | -43.27 | -72.41 | -32.68 |
| Performance Ratios | |||||
| ROA(%) | -13.54 | -25.51 | -19.36 | -20.91 | -14.92 |
| ROE(%) | - | - | - | - | - |
| ROCE(%) | -28.59 | -57.38 | -40.28 | -56.96 | -35.41 |
| Asset Turnover(x) | 0.29 | 0.34 | 0.37 | 0.24 | 0.36 |
| Sales/Fixed Asset(x) | 0.18 | 0.22 | 0.21 | 0.14 | 0.21 |
| Working Capital/Sales(x) | -1.58 | -1.40 | -2.01 | -1.38 | -2.00 |
| Efficiency Ratios | |||||
| Fixed Capital/Sales(x) | 5.67 | 4.60 | 4.69 | 7.15 | 4.86 |
| Receivable days | 4.91 | 3.60 | 1.71 | 17.00 | 12.36 |
| Inventory Days | 131.30 | 128.88 | 107.38 | 130.87 | 79.07 |
| Payable days | 378.02 | 263.51 | 305.42 | 507.31 | 309.62 |
| Valuation Parameters | |||||
| PER(x) | - | - | - | - | - |
| PCE(x) | -6.71 | -8.09 | -7.50 | -6.09 | -12.36 |
| Price/Book(x) | -1.22 | -4.12 | -3.72 | -4.52 | -13.50 |
| Yield(%) | - | - | - | - | - |
| EV/Net Sales(x) | 5.85 | 7.57 | 5.30 | 6.39 | 4.79 |
| EV/Core EBITDA(x) | -20.11 | -13.77 | -16.79 | -11.74 | -24.27 |
| EV/EBIT(x) | -14.04 | -11.55 | -12.90 | -9.33 | -16.68 |
| EV/CE(x) | 1.74 | 2.38 | 1.79 | 1.60 | 1.61 |
| M Cap / Sales | 2.33 | 5.18 | 3.25 | 4.41 | 4.04 |
| Growth Ratio | |||||
| Net Sales Growth(%) | -12.68 | 11.18 | 60.72 | -30.04 | 41.38 |
| Core EBITDA Growth(%) | 53.83 | -93.68 | 6.79 | -92.84 | -29.29 |
| EBIT Growth(%) | 44.50 | -77.25 | 3.45 | -66.64 | -8.41 |
| PAT Growth(%) | 44.55 | -57.01 | 1.78 | -44.28 | -12.27 |
| EPS Growth(%) | 44.55 | -42.89 | 9.89 | -33.30 | 7.22 |
| Financial Stability Ratios | |||||
| Total Debt/Equity(x) | -1.84 | -1.91 | -2.37 | -2.03 | -3.74 |
| Current Ratio(x) | 0.33 | 0.45 | 0.44 | 0.44 | 0.56 |
| Quick Ratio(x) | 0.08 | 0.13 | 0.10 | 0.09 | 0.40 |
| Interest Cover(x) | -7.30 | -7.26 | -3.52 | -3.81 | -2.18 |
| Total Debt/Mcap(x) | 1.51 | 0.46 | 0.64 | 0.45 | 0.28 |
Compare Financial Ratios of peers of KREBS BIOCHEMICALS & INDUSTRIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| KREBS BIOCHEMICALS & INDUSTRIES | ₹155.4 Cr | 2.3% | -9.4% | 3.7% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹364,015.0 Cr | 3% | 2.3% | 68.2% | Stock Analytics | |
| CIPLA | ₹108,809.0 Cr | 2.5% | 0.4% | 71.7% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹99,408.7 Cr | -0.2% | -4.9% | 40.3% | Stock Analytics | |
| DIVIS LABORATORIES | ₹98,684.0 Cr | -1.6% | -7% | 23.8% | Stock Analytics | |
| ZYDUS LIFESCIENCES | ₹94,213.7 Cr | 5% | 10.4% | 109.1% | Stock Analytics | |
KREBS BIOCHEMICALS & INDUSTRIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| KREBS BIOCHEMICALS & INDUSTRIES | 2.3% |
-9.4% |
3.7% |
| SENSEX | -2.9% |
-0.4% |
20% |
You may also like the below Video Courses
